Elan, Biogen present positive Tysabri data for Crohn's disease ...
Forbes - NY,USA
LONDON (AFX) - Elan Corporation PLC and Biogen Idec said conference data presented this week shows that their Tysabri drug maintained remission in Crohn's ...
See all stories on this topic

ISEQ up as Elan confidence drops
Ireland Online - Dublin,Ireland
Elan lost 30c (2.4%) to €12.00, after a survey in the US found that doctors are wary of prescribing the company’s multiple sclerosis drug Tysabri. ...